Literature DB >> 18843196

Alcohol and estrogen replacement therapy in postmenopausal women. Direct and mediated effects on cognitive component processes.

Laura J Tivis1, Natalie A Ceballos, Garvin Chastain, Rick D Tivis.   

Abstract

The literature remains contentious regarding the separate and combined effects of moderate drinking and estrogen replacement therapy (ERT) on cognition. In the current study, the authors sought to disentangle the predictive utility of alcohol use, ERT and their interaction on the episodic and semantic memory stores of postmenopausal women. It was predicted that relationships between moderate drinking, ERT and cognition would be attenuated by demographic and health-related factors. Postmenopausal women (n = 298) completed a battery of cognitive tests designed to assess speed and accuracy of episodic and knowledge-based cognitive processing. Potentially confounding variables were categorized and tested as mediators in hierarchical regression analyses. Moderate drinking was a weak predictor of episodic availability prior to removal of potential mediators. ERT use was a significant predictor of episodic and knowledge-based availability; no mediators were identified. Alcohol moderated ERT, as a combined alcohol/ERT variable was shown to be related to cognition. Neither moderate drinking nor ERT use was associated with cognitive speed. These findings suggest that positive relationships between alcohol and cognition are likely mediated by other variables, and should not be regarded as a benefit of drinking. Further, results support ERT as a predictor of knowledge-based and episodic availability, independent of mood stabilization or socioeconomic influences. Finally, alcohol and ERT appear to interact to impact both episodic and knowledge-based performance. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18843196      PMCID: PMC2723943          DOI: 10.1159/000162357

Source DB:  PubMed          Journal:  Neuropsychobiology        ISSN: 0302-282X            Impact factor:   2.328


  32 in total

1.  Postmenopausal estrogen and estrogen-progestin use and 2-year rate of cognitive change in a cohort of older Japanese American women: The Kame Project.

Authors:  M M Rice; A B Graves; S M McCurry; L E Gibbons; J D Bowen; W C McCormick; E B Larson
Journal:  Arch Intern Med       Date:  2000-06-12

2.  Cognitive performance in surgically menopausal women on estrogen.

Authors:  J Verghese; G Kuslansky; M J Katz; M Sliwinski; H A Crystal; H Buschke; R B Lipton
Journal:  Neurology       Date:  2000-09-26       Impact factor: 9.910

Review 3.  Progesterone-induced neuroprotection.

Authors:  Meharvan Singh
Journal:  Endocrine       Date:  2006-04       Impact factor: 3.633

4.  Hormone effects on fMRI and cognitive measures of encoding: importance of hormone preparation.

Authors:  C E Gleason; T W Schmitz; T Hess; R L Koscik; M A Trivedi; M L Ries; C M Carlsson; M A Sager; S Asthana; S C Johnson
Journal:  Neurology       Date:  2006-12-12       Impact factor: 9.910

5.  A 20-week randomized controlled trial of estradiol replacement therapy for women aged 70 years and older: effect on mood, cognition and quality of life.

Authors:  Osvaldo P Almeida; Nicola T Lautenschlager; Samuel Vasikaran; Peter Leedman; Anna Gelavis; Leon Flicker
Journal:  Neurobiol Aging       Date:  2005-03-16       Impact factor: 4.673

6.  Estrogen therapy selectively enhances prefrontal cognitive processes: a randomized, double-blind, placebo-controlled study with functional magnetic resonance imaging in perimenopausal and recently postmenopausal women.

Authors:  Hadine Joffe; Janet E Hall; Staci Gruber; Ingrid A Sarmiento; Lee S Cohen; Deborah Yurgelun-Todd; Kathryn A Martin
Journal:  Menopause       Date:  2006 May-Jun       Impact factor: 2.953

7.  Impact of combined estradiol and norethindrone therapy on visuospatial working memory assessed by functional magnetic resonance imaging.

Authors:  Yolanda R Smith; Tiffany Love; Carol C Persad; Anne Tkaczyk; Thomas E Nichols; Jon-Kar Zubieta
Journal:  J Clin Endocrinol Metab       Date:  2006-08-15       Impact factor: 5.958

8.  Hot flashes and estrogen therapy do not influence cognition in early menopausal women.

Authors:  Erin S LeBlanc; Michelle B Neiss; Phyllis E Carello; Mary H Samuels; Jeri S Janowsky
Journal:  Menopause       Date:  2007 Mar-Apr       Impact factor: 2.953

9.  Effects of ultra-low-dose transdermal estradiol on cognition and health-related quality of life.

Authors:  Kristine Yaffe; Eric Vittinghoff; Kristine E Ensrud; Karen C Johnson; Susan Diem; Vladimir Hanes; Deborah Grady
Journal:  Arch Neurol       Date:  2006-07

10.  Hormone therapy, timing of initiation, and cognition in women aged older than 60 years: the REMEMBER pilot study.

Authors:  Alastair H MacLennan; Victor W Henderson; Bronwen J Paine; Jane Mathias; Emmae N Ramsay; Philip Ryan; Nigel P Stocks; Anne W Taylor
Journal:  Menopause       Date:  2006 Jan-Feb       Impact factor: 2.953

View more
  3 in total

1.  Effects of alcohol- and cigarette-use disorders on global and specific measures of cognition in middle-age adults.

Authors:  Kristin Caspers; Stephan Arndt; Rebecca Yucuis; Lowell McKirgan; Ruth Spinks
Journal:  J Stud Alcohol Drugs       Date:  2010-03       Impact factor: 2.582

2.  Effect of concomitant progesterone administration or the effect of removal of estrogen capsule on changes caused by long-term estrogen treatment in pituitary VIP immunoreactivities.

Authors:  Andrea Heinzlmann; Katalin Köves; György M Nagy
Journal:  Endocrine       Date:  2010-03-30       Impact factor: 3.633

3.  Sexual dimorphism in the effect of concomitant progesterone administration on changes caused by long-term estrogen treatment in pituitary hormone immunoreactivities of rats.

Authors:  Andrea Heinzlmann; Katalin Koves; Magdolna Kovacs; Valer Csernus
Journal:  Med Sci Monit       Date:  2011-02-25
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.